Carmel Capital Partners LLC Increases Stock Holdings in HCA Healthcare, Inc. $HCA

Carmel Capital Partners LLC increased its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 11.1% during the 2nd quarter, Holdings Channel reports. The institutional investor owned 5,656 shares of the company’s stock after purchasing an additional 564 shares during the period. Carmel Capital Partners LLC’s holdings in HCA Healthcare were worth $2,167,000 as of its most recent SEC filing.

Other large investors have also added to or reduced their stakes in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in HCA Healthcare by 11.9% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,454 shares of the company’s stock valued at $8,796,000 after purchasing an additional 2,698 shares during the last quarter. Park Place Capital Corp grew its stake in HCA Healthcare by 2,336.0% during the 2nd quarter. Park Place Capital Corp now owns 1,218 shares of the company’s stock valued at $474,000 after purchasing an additional 1,168 shares during the last quarter. Harrell Investment Partners LLC grew its stake in HCA Healthcare by 176.3% during the 2nd quarter. Harrell Investment Partners LLC now owns 1,815 shares of the company’s stock valued at $695,000 after purchasing an additional 1,158 shares during the last quarter. Brown Advisory Inc. grew its stake in HCA Healthcare by 53.9% during the 1st quarter. Brown Advisory Inc. now owns 4,630 shares of the company’s stock valued at $1,600,000 after purchasing an additional 1,622 shares during the last quarter. Finally, Oppenheimer Asset Management Inc. lifted its holdings in shares of HCA Healthcare by 2.5% in the 1st quarter. Oppenheimer Asset Management Inc. now owns 4,314 shares of the company’s stock valued at $1,491,000 after buying an additional 105 shares during the period. Hedge funds and other institutional investors own 62.73% of the company’s stock.

HCA Healthcare Trading Up 1.4%

NYSE:HCA opened at $425.50 on Friday. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $439.01. The stock has a 50 day moving average of $410.05 and a two-hundred day moving average of $378.21. The firm has a market cap of $99.56 billion, a P/E ratio of 17.89, a price-to-earnings-growth ratio of 1.33 and a beta of 1.40.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Friday, July 25th. The company reported $6.84 EPS for the quarter, topping the consensus estimate of $6.20 by $0.64. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The company had revenue of $18.61 billion during the quarter, compared to analyst estimates of $18.49 billion. During the same period in the previous year, the business earned $5.50 EPS. HCA Healthcare’s quarterly revenue was up 6.4% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. On average, research analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th were paid a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a yield of 0.7%. The ex-dividend date was Tuesday, September 16th. HCA Healthcare’s payout ratio is 12.11%.

Analyst Ratings Changes

Several equities analysts have recently issued reports on the company. UBS Group boosted their price objective on HCA Healthcare from $438.00 to $495.00 and gave the company a “buy” rating in a report on Tuesday. Bank of America boosted their price objective on HCA Healthcare from $375.00 to $410.00 and gave the company a “neutral” rating in a report on Wednesday, September 10th. Wolfe Research cut HCA Healthcare from an “outperform” rating to a “peer perform” rating in a report on Monday, July 28th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $444.00 price target on shares of HCA Healthcare in a report on Tuesday, October 7th. Finally, Mizuho upped their price target on HCA Healthcare from $425.00 to $475.00 and gave the stock an “outperform” rating in a report on Friday. One research analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and nine have given a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $434.00.

Insider Activity

In other news, EVP Michael S. Cuffe sold 3,836 shares of the company’s stock in a transaction that occurred on Monday, September 8th. The stock was sold at an average price of $418.84, for a total value of $1,606,670.24. Following the completion of the sale, the executive vice president directly owned 31,503 shares in the company, valued at $13,194,716.52. This represents a 10.85% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 1.30% of the stock is owned by company insiders.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.